Year
Edition number
№12 / 2019
REVIEWS
N.A. Brish (1), T.Yu.Semiglazova (1, 2), P.A.Zakharova (1), A.V.Mishchenko (1), B.S.Kasparov (1), S.A. Protsenko (1), G.M.Teletaeva (1), D.Kh.Latipova (1), A.I.Semenova (1), E.V.Tkachenko (1), Yu.V.Alekseeva (1), Ya.A. Ulyanchenko (1), L.V.Filatova (1), V.V. Semiglazov (1, 3)
The predictive value of nutritional deficiency in the treatment of patients with locally advanced stomach cancer9-14
E.V. Glazkova, M.A. Frolova, S.F. Menshikov, M.B. Stenina
Experience of the use of ixabepilone in polychemotherapy regimens for disseminated triple-negative breast cancer15-18
ORIGINAL ARTICLES
Kh.B. Kotiv (1, 2), M.G. Yakovleva (1), A.P. Sokolenko (1), T.V. Gorodnova (1), A.O. Ivantsov (1), E.A. Nekrasova (1), O.A. Smirnova (1), A.A. Sidoruk (1, 2), N.E. Bondarev (1), I.E. Meshkova (1), N.A. Mikaya (1), S.V. Petrik (1), A.F. Urmancheeva (1, 2), E.A. Ulrikh (1, 2), S.A. Protsenko (1), A.M. Belyaev (1, 2), E.N. Imyanitov (1, 2), I.V. Berlev (1, 2)
A prospective non-randomized trial: the use of platinum-containing chemotherapy with mitomycin for relapses of brca1-associated ovarian cancer19-25
G.A. Khakimov (1, 2), Kh.I. Dzhumaniezov (1, 2), Sh.Sh. Kadyrov (1, 2), G.G. Khakimova (3), S.I. Abdulkhuseynova (3), I.N. Poluzhkina (3)
Influence of FOLFIRINOX on the achievement of resistability in patients with rectal and liver metastases26-36
O.A. Smirnova (1), N.E. Bondarev (1), E.A. Ulrikh (1, 2), N.A. Mikaya (1), Kh.B. Kotiv (1, 2), A.S. Petrova (1), A.O. Ivantsov (1), T.V. Gorodnova (1), E.A. Nekrasova (1), O.E. Lavrinovich (1), M.G. Yakovleva (1), A.V. Abramova (1), D.V. Malyutina (1), Sh.G. Parsyan (1), G.B. Mkrtchyan (1), Z.N. Ibragimov (1), Yu.N. Trifanov (1), A.A. Sidoruk (1), A.F. Urmancheeva (1, 2), I.V. Berlev (1, 2)
Assessment of intensified neoadjuvant chemotherapy regimens for locally advanced cervical cancer37-43
R.V. Orlova (1, 2, 5), А.К. Ivanova (2), G.A. Raskin (3), S.I. Kutukova (2, 4), A.V. Androsova (2), S.P. Erdniev (2), N.V. Zhukova (1, 2), N.P. Belyak (1, 2), N.V. Popova (2), I.V. Avramenko (2), N.Yu. Antimonik (2), E.Yu. Zorina (2)
CXCR4 chemokine receptor expression in tumor tissue as an additional predictor factor for patients with colon cancer44-49
O.V. Smirnova (1), V.V. Tsukanov (1), A.A. Modestov (3), A.A. Sinyakov (1), O.L. Moskalenko (1), N.G. Elmanova (1), E.S. Ovcharenko (1), N.M. Titova (2)
Interim assesment of the results of a clinical study of the regularities of changes in the patterns of lipid peroxidation - antioxidant defence in stomach cancer50-55
S.I. Kutukova (1, 2), E.N. Imyanitov (3), Yu.V. Ivaskova (1, 2), N.P. Belyak (1, 4), A.Ya. Razumova (2)
Evaluation of RET mRNA expression in malignant tumors of the salivary glands56-58
I.V. Kolyadina
New results of combination endocrinotherapy with ribocyclib60-65
CLINICAL GUIDELINES
V.A. Gorbunova
Neuroendocrine tumors: current changes in the classification, diagnosis and therapy presented in the draft clinical guidelines of the Ministry of Health of the Russian Federation 201966-73
V.F. Semiglazov (1), V.V. Semiglazov (2)
Adjuvant and neoadjuvant therapy for (based on the materials of the 16th St. Gallen International Breast Cancer Conference)74-79
M.E. Abramov, Y.E. Chikhareva, M.Sh. Manukyan, E.A. Prokofiev, G.V. Vyshinskaya
The role of erythropoietin preparations in the treatment of anemia in oncologic patients80-84
T.V. Ustinova (1), L.V. Bolotina (1), N.V. Kharchenko (2), A.A. Paichadze (1), B.Ya. Alekseev (1), A.L. Kornietskaya (1), K.M. Isaeva (3), A.A. Kachmazov (1), A.D. Kaprin (1), A.A. Fedenko (1)
Neoadjuvant and adjuvant chemohormonotherapy in patients with prostate cancer with high risk for progression86-91
R.I. Nuriev (1, 2), M.I. Sekacheva (1), A.P. Bondarenko (2), M.P. Baranova (2, 3), S.Yu. Sletina (2), E.V. Poddubskaya (1, 2)
Emergency care in oncology: potential complications of treatment with immune checkpoint inhibitors92-99
Yu.V. Vakhabova (1), A.A. Kolomeytseva (1), D.V. Kalinin (2), E.N. Kozak (3), A.A. Fedenko (1)
Pembrolizumab in the treatment of patients with non-small cell lung cancer and metastatic brain lesion: a clinical review100-106
S.L. Gutorov, E.I. Borisova, K.A. Ivanova, M.Sh. Manukyan, S.I. Abdulkhuseinova
Primary multiple colonic tumors of various genetic characteristics in a patient with familial adenomatous polyposis: description of the clinical case107-111
S.V. Khokhlova
Optimal treatment strategy for a patient with advanced ovarian cancer without deterioration in the quality of life: a clinical case112-119
A.V. Fateeva (1), A.V.Zyuzyukina (2), R.A. Zukov (2)
A clinical case of using ribociclib with an aromatase inhibitor in metastatic hormone-receptor-positive HER2-negative breast cancer with a rare location of metastasis121-125
